Trial intelligence / Profile preview

Larotrectinib phase 2 basket study in NTRK fusion-positive tumors

2015-003582-28Phase 2

Sponsor

Bayer Consumer Health

Start

Jan 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1